SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

NATCO PHARMA

BSE: 524816 22 Aug 2025
Healthcare
₹ 882.7
Natco Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

NATCO PHARMA - Share Price & Details

Market Cap
₹15,823
High /Low
1,639 / 660.0
Stock P/E
9.36
Book Value
₹425.0
Dividend Yield
0.68
ROCE
32.8
ROE
₹28.0
Face Value
2.0
PEG Ratio
0.07
EVEBITDA
₹5.97
Debt
279
CMP / FCF
16.8
Debt to equity
₹0.04
NP Ann
1,883
High price all time
1,639
Piotroski score
₹8.0
Graham Number
952.0
No. Eq. Shares
17.9
Net CF
₹71.6
Net profit
1,695
Price to book value
2.06
Interest Coverage
₹95.0
Low price all time
7.6
Industry PE
32.8
Reserves
₹7,571
Free Cash Flow
₹1,300

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
NATCO PHARMA LTD.12523.04641.011927.025.9115,8239.36
Blue Jet Healthcare Limited3630.12911.73547.585.261336937.3
SANOFI INDIA LTD4150.0695.04063.030.181202627.2

Peer Comparison Chart


About NATCO PHARMA

Natco Pharma Ltd., with Security Code 524816, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Natco Pharma launches tablets to treat pulmonary arterial hypertension

(20 Aug 2025)
Natco Pharma said it holds the first-to-file status for this product and will have 180-day generic drug exclusivity.
Read more →

Natco Pharma Launches Generic Drug in US

(20 Aug 2025)
Natco Pharma launches generic Bosentan tablets for pulmonary hypertension in the US with 180-day exclusivity. Partnering with Lupin Ltd.
Read more →

Natco Pharma Launches Oral Drug: Shares Slump 1%

(20 Aug 2025)
Shares of Natco Pharma Ltd were trading in the red and 1% lower on Wednesday, 20 August, despite the company announcing the launch of oral...
Read more →

Natco Pharma launches generic drug with 180-day exclusivity in US

(20 Aug 2025)
Natco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young...
Read more →

Lupin, Natco Launch Bosentan Tablets in US With 180-Day Exclusivity

(20 Aug 2025)
Mumbai: Global pharma major Lupin Limited on Wednesday announced the launch of Bosentan Tablets for Oral Suspension, 32 mg in the United...
Read more →

Dividend Stocks: HAL, Godfrey Phillips, Coal India, among others to trade ex-dividend next week; Full list

(16 Aug 2025)
Dividend Stocks: Companies including Hindustan Aeronautics (HAL), Godfrey Phillips India, Coal India, Senco Gold, Rail Vikas Nigam Ltd,...
Read more →

Company Updates